eXoZymes, Inc. Market Cap ($36.54 Million)
Market Cap & Net Worth: eXoZymes, Inc. (EXOZ)
eXoZymes, Inc. market cap. eXoZymes, Inc. (NASDAQ:EXOZ) has a market capitalization of $36.54 Million ($36.54 Million) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #22858 globally and #5033 in its home market, demonstrating a 13.42% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying eXoZymes, Inc.'s stock price $4.31 by its total outstanding shares 8478992 (8.48 Million). Also see how efficiently does eXoZymes, Inc. generate cash for how efficiently the company converts equity into cash flow.
eXoZymes, Inc. Market Cap History (2025–2026)
eXoZymes, Inc. market cap history from 2025 to 2026. Data shows change from $92.42 Million to $36.54 Million (-58.08% CAGR). Check eXoZymes, Inc. (EXOZ) share price today for real-time trading data and today's change.
Index Memberships
eXoZymes, Inc. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.00% | #647 of 976 |
Weight: eXoZymes, Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
eXoZymes, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how eXoZymes, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore eXoZymes, Inc. (EXOZ) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of EXOZ by Market Capitalization
Companies near eXoZymes, Inc. in the global market cap rankings as of November 5, 2026. Also see eXoZymes, Inc. balance sheet assets for a full breakdown of the balance sheet.
Key companies related to eXoZymes, Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #181 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #373 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #415 globally with a market cap of $67.74 Billion USD ( AU$95.74 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #503 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #181 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $549.04 |
| #373 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $930.67 |
| #415 | CSL Ltd | AU:CSL | $67.74 Billion | AU$197.34 |
| #503 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $258.38 |
Market Capitalization of eXoZymes, Inc. (2025–2026)
Market capitalization of eXoZymes, Inc. from 2025 to today. Between 2025 and today, eXoZymes, Inc.'s market cap moved from $92.42 Million to $ 36.54 Million, with a yearly change of -58.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $36.54 Million | -60.46% |
| 2025 | $92.42 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of eXoZymes, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $36.54 Million USD |
| MoneyControl | $36.54 Million USD |
| MarketWatch | $36.54 Million USD |
| marketcap.company | $36.54 Million USD |
| Reuters | $36.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About eXoZymes, Inc.
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.